Operating

Neurocrine Biosciences·Cash Flow Statement·26 metrics

Breakdown

Loading...

Metrics

Amortization of intangible assets

Amortization of Investment Discount and Premium

Accretion (amortization) of discounts and premiums on investments

Change in accounts payable

Change in accounts receivable

Change in income taxes payable/receivable

Other working capital changes

Deferred income taxes

Depreciation and amortization

Net gains (losses) on investments

Gain (loss) on sale of assets

Gain (loss) on disposal of group

Accretion (Amortization) of Investment Discounts and Premiums

Gain (Loss) on Disposal Group

Gain (Loss) on Disposal of Group (Not Discontinued Operation)

Net cash from operating activities

Net income

Accretion (Amortization) of Discounts and Premiums, Investments

Amortization of capitalized software and acquired intangible assets

Non-cash operating lease expense

Operating lease right-of-use asset amortization

Non-cash lease expense

Pre-tax Gain on Disposal of Business

Accretion (Amortization) of Investment Discounts and Premiums

Stock-based compensation

Gain (Loss) on Disposal Group Not Discontinued Operation